NEOGEN CEO granted stock options and PSUs
NEOGEN CORP CEO Mikheal Nassif reported two equity awards on August 14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEOGEN CORP CEO Mikheal Nassif reported two equity awards on August 14, 2026. He received options for 719,679 shares of common stock at an exercise price of $11.65 per share, expiring on August 14, 2036; these options vest in equal annual installments over three years. He also received 141,631 performance stock units (PSUs), which vest in total on the three-year anniversary of the grant. Following these awards, reported direct holdings are 141,631 common shares and 719,679 option-based rights.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) F2 | 719,679 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 141,631 | $11.65 | $1.65M |
Footnotes (2)
- F1. PSUs vest in total at the end of the three year anniversary date of the grant
- F2. Options vest in equal annual installments on each of the first three anniversary dates of the grants
Key Figures
Key Terms
performance stock units financial
vesting financial
exercise price financial
expiration date financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did NEOG (NEOGEN CORP) CEO Mikheal Nassif receive in this Form 4?
What are the vesting terms of the stock options reported for NEOG CEO Nassif?
How do the performance stock units (PSUs) for NEOG CEO Nassif vest?
What is the exercise price and expiration date of NEOG CEO Nassif’s stock options?
Were the NEOG CEO’s reported transactions open-market buys or compensation grants?
AI-generated analysis. How Rhea-AI works. Not financial advice.